Abbisko Cayman Limited (HKG:2256)
Hong Kong · Delayed Price · Currency is HKD 12.85
-0.25 (-1.91%)
Feb 13, 2026, 4:08 PM HKT
Abbisko Cayman Market Cap
Abbisko Cayman has a market cap or net worth of 8.81 billion as of February 13, 2026. Its market cap has increased by 194.70% in one year.
Market Cap
8.81B
Enterprise Value
6.34B
Revenue
678.11M
Ranking
n/a
PE Ratio
53.68
Stock Price
12.85
Market Cap Chart
Since October 15, 2021, Abbisko Cayman's market cap has increased from 8.71B to 8.81B, an increase of 1.12%. That is a compound annual growth rate of 0.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 8.81B | 0.69% |
| Dec 31, 2025 | 8.75B | 204.13% |
| Dec 31, 2024 | 2.88B | 21.63% |
| Dec 29, 2023 | 2.36B | 4.97% |
| Dec 30, 2022 | 2.25B | -64.77% |
| Dec 31, 2021 | 6.39B | -26.60% |
| Oct 15, 2021 | 8.71B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Everest Medicines | 13.51B |
| Guangzhou Innogen Pharmaceutical Group | 12.49B |
| Nanjing Leads Biolabs | 12.09B |
| Shanghai Haohai Biological Technology | 10.95B |
| HBM Holdings | 9.85B |
| Alphamab Oncology | 8.62B |
| Lepu Biopharma | 8.32B |
| CStone Pharmaceuticals | 8.25B |